Raffaella Parente
Overview
Explore the profile of Raffaella Parente including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doni A, Sironi M, Del Prete A, Pasqualini F, Valentino S, Cuccovillo I, et al.
Front Immunol
. 2024 Dec;
15:1426869.
PMID: 39640269
Introduction: The lymphatic system is a multifaceted regulator of tissue homeostasis and an integral part of immune responses. Previous studies had shown that subsets of lymphatic endothelial cells (LEC) express...
2.
Erreni M, Fumagalli M, DAnna R, Sollai M, Bozzarelli S, Nappo G, et al.
Front Immunol
. 2024 Nov;
15:1472433.
PMID: 39575252
Introduction: Pancreatic ductal adenocarcinoma (PDAC) represents the complexity of interaction between cancer and cells of the tumor microenvironment (TME). Immune cells affect tumor cell behavior, thus driving cancer progression. Cancer-associated...
3.
Delliere S, Chauvin C, Wong S, Gressler M, Possetti V, Parente R, et al.
Nat Commun
. 2024 Aug;
15(1):6966.
PMID: 39138196
Pentraxin 3 (PTX3), a long pentraxin and a humoral pattern recognition molecule (PRM), has been demonstrated to be protective against Aspergillus fumigatus, an airborne human fungal pathogen. We explored its...
4.
Erreni M, Fumagalli M, Zanini D, Candiello E, Tiberi G, Parente R, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338669
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. PDAC is characterized by a complex tumor microenvironment (TME), that plays a pivotal role in disease progression and resistance...
5.
Ma Y, Parente R, Zhong H, Sun Y, Garlanda C, Doni A
Biomed Pharmacother
. 2023 Nov;
169:115878.
PMID: 37952357
The complement is a crucial immune defense system that triggers rapid immune responses and offers efficient protection against foreign invaders and unwanted host elements, acting as a sentinel. Activation of...
6.
Parente R, Fumagalli M, Di Claudio A, Cardenas Rincon C, Erreni M, Zanini D, et al.
Pathogens
. 2023 Sep;
12(9).
PMID: 37764949
The recognition of microbe and extracellular matrix (ECM) is a recurring theme in the humoral innate immune system. Fluid-phase molecules of innate immunity share regulatory roles in ECM. On the...
7.
Porte R, Silva-Gomes R, Theroude C, Parente R, Asgari F, Sironi M, et al.
Elife
. 2023 May;
12.
PMID: 37222419
is a major pathogen in children, elderly subjects, and immunodeficient patients. Pentraxin 3 (PTX3) is a fluid-phase pattern recognition molecule (PRM) involved in resistance to selected microbial agents and in...
8.
Erreni M, DAutilia F, Avigni R, Bolli E, Arnouk S, Movahedi K, et al.
Theranostics
. 2023 Jan;
13(1):355-373.
PMID: 36593955
Nanobodies (Nbs) have emerged as an elegant alternative to the use of conventional monoclonal antibodies in cancer therapy, but a detailed microscopic insight into the pharmacokinetics of different Nb formats...
9.
Granata V, Possetti V, Parente R, Bottazzi B, Inforzato A, Sobacchi C
Front Immunol
. 2022 Dec;
13:1048505.
PMID: 36483565
Osteomyelitis (OM) is an infectious disease of the bone predominantly caused by the opportunistic bacterium (). Typically established upon hematogenous spread of the pathogen to the musculoskeletal system or contamination...
10.
Parente R, Possetti V, Erreni M, DAutilia F, Bottazzi B, Garlanda C, et al.
Front Immunol
. 2021 Dec;
12:785883.
PMID: 34868070
The ubiquitous mold is the major etiologic agent of invasive aspergillosis, a life-threatening infection amongst immune compromised individuals. An increasing body of evidence indicates that effective disposal of requires the...